Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.34 USD
Change Today -0.09 / -6.29%
Volume 87.4K
SNGX On Other Exchanges
Symbol
Exchange
Berlin
OTC BB
As of 5:19 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher J. Schaber Ph.D.

Chairman, Chief Executive Officer and President,Soligenix, Inc.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 2 different organizations across 3 different industries.

See Board Relationships
48$706,580
As of Fiscal Year 2014

Background*

Dr. Christopher J. Schaber, Ph.D., has been the President and Chief Executive Officer at Soligenix, Inc. (Formerly DOR BioPharma Inc.) since August 30, 2006. Dr. Schaber has more than 23 years experience in the pharmaceutical and biotechnology industry. Prior to joining the company, Dr. Schaber served from 1998 to 2006 as an Executive Vice President and Chief Operating Officer of Discovery Laboratories, Inc., where he was responsible for overall pipeline development ...

Read Full Background

Corporate Headquarters*

29 Emmons Drive
Princeton, New Jersey 08540

United States

Phone: 609-538-8200
Fax: 609-452-6467

Board Members Memberships*

Trustee
2006-Present
Chairman, Chief Executive Officer and President

Education*

MS
Temple University
BA
Western Maryland College
PhD
Union Graduate School

Other Affiliations*

Annual Compensation*

Salary$412,000
Bonus$115,000
Total Annual Compensation$527,000

Stock Options*

All Other Compensation$29,580
Exercisable Options704,685
Unexercisable Options157,500
Total Number of Options1,019,685

Total Compensation*

Total Annual Cash Compensation$556,580
Total Short Term Compensation$527,000
Other Long Term Compensation$29,580
Total Calculated Compensation$706,580
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNGX:US $1.34 USD -0.09

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLIGENIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.